Posttreatment controllers: What do they tell us?

Current Opinion in HIV and AIDS

Volumn 10, Issue 1, 2015, Pages 29-34

  Rouzioux, Christine ^a   Hocqueloux, Laurent ^b   Sáez Cirion, Asier ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

Control of viremia; HIV remission; Posttreatment controllers; Treatment in acute infection

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

CD4+ T LYMPHOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION; INFECTION CONTROL; LYMPHOID TISSUE; MEMORY CELL; POSTTREATMENT CONTROLLER; PRIMARY INFECTION; REMISSION; REVIEW; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; VIREMIA; VIROLOGY; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD; VIREMIA;

EID: 84918505397     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000123     Document Type: Review

References (36)

1. Saez-Cirion A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013; 9:e1003211.
2. Saez-Cirion A, Pancino G. HIV controllers: a genetically determined or inducible phenotype? Immunol Rev 2013; 254:281-294.
3. Hocqueloux L, Prazuck T, Avettand-Fenoel V, et al. Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection. AIDS 2010; 24:1598-1601.
4. Goujard C, Girault I, Rouzioux C, et al. HIV-1 control after transient antire-troviral treatment initiated in primary infection: role of patient characteristics and effect of therapy. Antivir Ther 2012; 17:1001-1009.
5. Lodi S, Meyer L, Kelleher AD, et al. Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion. Arch Intern Med 2012; 172:1252-1255.
6. Van Gulck E, Bracke L, Heyndrickx L, et al. Immune and viral correlates of 'secondary viral control' after treatment interruption in chronically HIV-1 infected patients. PLoS One 2012; 7:e37792.
7. Salgado M, Rabi SA, O'Connell KA, et al. Prolonged control of replication-competent dual-tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy. Retrovirology 2011; 8:97.
8. Hocqueloux L, Avettand-Fenoel V, Jacquot S, et al. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T-cell counts. J Antimicrob Chemother 2013; 68:1169-1178.
9. Archin NM, Vaidya NK, Kuruc JD, et al. Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci USA 2012; 109:9523-9528.
10. Gianella S, von Wyl V, Fisher M, et al. Effect of early antiretroviral therapy during primary infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir Ther 2011; 16:535-545.
11. Wyl V, Gianella S, Fisher M, et al. Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS One 2011; 6:e27463.
12. Ananvoranitch J, Puthanakit T, Suntarattiwong P, et al. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children. AIDS 2014; 28:1015-1020.
13. Chamberland A, Sylla M, Boulassel MR, et al. Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection. Int J STD AIDS 2011; 22:146-150.
14. Moir S, Buckner CM, Ho J. B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation on anti-retroviral therapy. Blood 2010; 116:5571-5579.
15. Kôk A, Hocqueloux L, Hocini H, et al. Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients. Mucosal Immunol 2014; Jul 2. doi:10.1038/mi.2014.50. [Epub ahead of print]
16. Ananvoranitch J, Schuetz A, Vandergeeten C, et al. Impact of multitargeted antiretroviral treatment on gut T-cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 2012; 7:e33948.
17. Jain V, Hartogensis W, Bachetti P, et al. Antiretroviral therapy initiated within 6 months fo infection is associated with lower T-cell activation ans smaller HIV reservoir size. J Infect Dis 2013; 208:1202-1211.
18. Fiedler S, Porter K, Ewings F, et al. Short-course antiretroviral therapy in primary infection. N Engl J Med 2013; 368:207-217.
19. Stohr W, Fiedler S, Mc Clure M, et al. Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy. PLoS One 2013; 8:e78287.
20. Tomescu C, Duh FM, Hoh R, et al. Impact of protective killer inhibitory receptor human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers. AIDS 2012; 26:1869-1878.
21. Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T-cell survival and homeostatic proliferation. Nat Med 2009; 15:893-900.
22. Descours B, Avettand-Fenoel V, Blanc C, et al. Immune responses driven by protective human leukocyte alleles from long-term nonprogressors are associated with low reservoirs in cental memory CD4 T cells. Clin Infect Dis 2012; 54:1495-1503.
23. Bacchus C, Cheret A, Avettand-Fenoel V, et al. A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month postinfection. PLoS One 2013; 8:e64219.
24. Ananvoranitch J, Vandergeeten C, Chomchey N et al. Early ART intervention restricts the seeding of the HIV reservoir in long-lived central memory CD4 T cells. 20th Conference on Retroviruses and Opportunistic infections. 2013, Atlanta, GA, USA.
25. Buzon MJ, Martin-Gayo E, Pereyra F, et al. Long-term antiretroviral treatment initiated in primary HIV-1 infection affects the size, composition and decay kinetics of the reservoir of HIV-1 infected CD4 T cells. J Virol 2014; 88:10056-10065.
26. Murray JM, Zaunders JJ, McBride KL, et al. HIV DNA subspecies persist in both activated and resting memory CD4 T cells during antiretroviral therapy. J Virol 2014; 88:3516-3526.
27. Rouzioux C, Richman D. How to best measure HIV reservoirs? Curr Opin HIV AIDS 2013; 8:170-175.
28. Rouzioux C, Melard A, Avettand-Fenoel V. Quantification of total HIV1-DNA in peripheral blood mononuclear cells. Methods Mol Biol 2014; 1087:261-270.
29. Eriksson S, Graf EH, Dahl V, et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog 2013; 9:e1003174.
30. Henrich TJ, Hu Z, Sciarangghelle G, et al. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogenic stem cell transplantation. J Infect Dis 2013; 207:1694-1702.
31. Persaud D, GAY H, Zeemniak C, et al. Absence of detectable viremia after treatment cessation in an infant. N Engl J Med 2013; 369:1828-1835.
32. Fletcher CV, Staskus K, Wietgrefe SW, et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci USA 2014; 11:2307-2312.
33. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf.
34. Hoen B, Bonnet F, Delaugerre C, et al. French 2013 guidelines for anti-retroviral therapy of HIV-1 infection in adults. J Int AIDS Soc 2014; 17:19034. doi: 10.7448/IAS.17.1.19034. eCollection 2014.
35. Hamimi C, Pancino G, Barre-Sinoussi F, Saez-Cirion A. Will it be possible to live without antiretroviral therapy? Curr Opin HIV AIDS 2013; 8:196-203.
36. Pandrea I, Gaufin T, Gautman R, et al. Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T-cells and is reverted by CD8+ cell depletion. PLoS Pathog 2011; 7: e1002170.